In last trading session, Compass Therapeutics Inc (NASDAQ:CMPX) saw 0.47 million shares changing hands with its beta currently measuring 0.72. Company’s recent per share price level of $1.70 trading at $0.05 or 3.03% at ring of the bell on the day assigns it a market valuation of $233.90M. That closing price of CMPX’s stock is at a discount of -112.94% from its 52-week high price of $3.62 and is indicating a premium of 32.35% from its 52-week low price of $1.15. Taking a look at company’s average trading volume volume of 371.21K if we extend that period to 3-months.

Compass Therapeutics Inc (NASDAQ:CMPX) trade information

Upright in the green during last session for gaining 3.03%, in the last five days CMPX remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $1.70 price level, adding 5.03% to its value on the day. Compass Therapeutics Inc’s shares saw a change of 8.97% in year-to-date performance and have moved 17.24% in past 5-day. Compass Therapeutics Inc (NASDAQ:CMPX) showed a performance of -2.30% in past 30-days.

Compass Therapeutics Inc (CMPX) estimates and forecasts

Statistics highlight that Compass Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -3.95% of value to its shares in past 6 months, showing an annual growth rate of -45.45% while that of industry is 12.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.88% during past 5 years.

CMPX Dividends

Compass Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.